NCT00417807 - Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2009

Conditions

Refractory Desmoplastic Small Round Cell Tumors

Interventions

DRUG

Imatinib mesilate

Trial Locations (8)

Novartis Investigative Site, Ivrea

Novartis Investigative Site, Milan

Novartis Investigative Site, Napoli

Novartis Investigative Site, Padua

Novartis Investigative Site, Ravenna

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Torino

Novartis Investigative Stie, Vatania